Due to the compounds plasma half-life of approximately 3.86.9 hours [5] , twice-daily (BID) dosing may provide more sustained NNMT inhibition
If it climbs higher, stays elevated past 2 weeks, or causes symptoms, stop and consult a clinician
What makes 5-Amino-1MQ especially promising is its ability to selectively target adipose (fat) tissue without affecting muscle tissue, making it an intriguing option for weight management and overall metabolic support
Human safety data is limited, so its full risk profile is not established
It is not a peptide in the traditional sense but is commonly grouped with research peptides in the metabolic optimization space
They can cause significant muscle loss along with fat loss, which some research suggests may be as high as 30-40% of total weight lost